The bispecific B7H3xCD3 antibody CC-3 induces T cell immunity against bone and soft tissue sarcomas
Sarcomas are rare and heterogeneous malignancies that are difficult to treat. Approximately 50% of patients diagnosed with sarcoma develop metastatic disease with so far very limited treatment options. The transmembrane protein B7-H3 reportedly is expressed in various malignancies, including differe...
| Published in: | Frontiers in Immunology |
|---|---|
| Main Authors: | Samuel J. Holzmayer, Kai Liebel, Ilona Hagelstein, Helmut R. Salih, Melanie Märklin |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2024-05-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2024.1391954/full |
Similar Items
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
by: Susanne Jung, et al.
Published: (2024-02-01)
by: Susanne Jung, et al.
Published: (2024-02-01)
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer
by: S. M. Greiner, et al.
Published: (2025-07-01)
by: S. M. Greiner, et al.
Published: (2025-07-01)
Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer
by: Sylwia A. Stefańczyk, et al.
Published: (2025-07-01)
by: Sylwia A. Stefańczyk, et al.
Published: (2025-07-01)
B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
by: Ilona Hagelstein, et al.
Published: (2022-10-01)
by: Ilona Hagelstein, et al.
Published: (2022-10-01)
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment
by: Julia M. Ott, et al.
Published: (2025-08-01)
by: Julia M. Ott, et al.
Published: (2025-08-01)
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer
by: Martina S. Lutz, et al.
Published: (2023-04-01)
by: Martina S. Lutz, et al.
Published: (2023-04-01)
Targeting CD276 for T cell-based immunotherapy of breast cancer
by: Ilona Hagelstein, et al.
Published: (2024-10-01)
by: Ilona Hagelstein, et al.
Published: (2024-10-01)
1366 B7-H3xCD3 bispecific antibody as novel treatment option in HER2-negative breast cancer
by: Ilona Hagelstein, et al.
Published: (2023-11-01)
by: Ilona Hagelstein, et al.
Published: (2023-11-01)
Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody
by: Sylwia A. Stefańczyk, et al.
Published: (2024-04-01)
by: Sylwia A. Stefańczyk, et al.
Published: (2024-04-01)
An IgG‐based bispecific antibody for improved dual targeting in PSMA‐positive cancer
by: Latifa Zekri, et al.
Published: (2020-12-01)
by: Latifa Zekri, et al.
Published: (2020-12-01)
1390 A Fc-optimized B7-H3 antibody for induction of NK cell reactivity against acute myeloid leukemia
by: Melanie Märklin, et al.
Published: (2023-11-01)
by: Melanie Märklin, et al.
Published: (2023-11-01)
A novel IgG-based FLT3xCD3 bispecific antibody for the treatment of AML and B-ALL
by: Melanie Märklin, et al.
Published: (2022-03-01)
by: Melanie Märklin, et al.
Published: (2022-03-01)
965 NFAT2 drives the cytoskeletal remodeling of leukemia cells, which regulates their vulnerability to perforin-mediated killing
by: Melanie Märklin, et al.
Published: (2023-11-01)
by: Melanie Märklin, et al.
Published: (2023-11-01)
Selinexor Sensitizes TRAIL-R2-Positive TNBC Cells to the Activity of TRAIL-R2xCD3 Bispecific Antibody
by: Silvia Martini, et al.
Published: (2020-10-01)
by: Silvia Martini, et al.
Published: (2020-10-01)
Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers
by: Anja Seckinger, et al.
Published: (2023-12-01)
by: Anja Seckinger, et al.
Published: (2023-12-01)
1353 An Fc-optimized B7-H3-targeting antibody for treatment of ovarian cancer
by: Ilona Hagelstein, et al.
Published: (2023-11-01)
by: Ilona Hagelstein, et al.
Published: (2023-11-01)
Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)
by: Kübra Kaban, et al.
Published: (2021-11-01)
by: Kübra Kaban, et al.
Published: (2021-11-01)
An Fc-modified monoclonal antibody as novel treatment option for pancreatic cancer
by: Martina S. Lutz, et al.
Published: (2024-01-01)
by: Martina S. Lutz, et al.
Published: (2024-01-01)
Targeting CEACAM5-positive solid tumors using NILK-2401, a novel CEACAM5xCD47 κλ bispecific antibody
by: Anja Seckinger, et al.
Published: (2024-04-01)
by: Anja Seckinger, et al.
Published: (2024-04-01)
Diamondback Moth, Plutella xylostella (Linnaeus) (Insecta: Lepidoptera: Plutellidae)
by: John L. Capinera
Published: (2002-11-01)
by: John L. Capinera
Published: (2002-11-01)
Environmental and Economic Benefits of Selecting Beef Cattle for Feed Efficiency
by: Nicolas DiLorenzo, et al.
Published: (2012-03-01)
by: Nicolas DiLorenzo, et al.
Published: (2012-03-01)
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
by: Melanie Märklin, et al.
Published: (2022-02-01)
by: Melanie Märklin, et al.
Published: (2022-02-01)
Integrated Management of White Mold on Vegetables in Florida
by: Mathews L. Paret, et al.
Published: (2018-01-01)
by: Mathews L. Paret, et al.
Published: (2018-01-01)
Herbicides for Highway Rights-of-Way
by: Jason A. Ferrell, et al.
Published: (2007-10-01)
by: Jason A. Ferrell, et al.
Published: (2007-10-01)
Florida Fresh: Blueberries
by: Jennifer Hillan
Published: (2002-07-01)
by: Jennifer Hillan
Published: (2002-07-01)
Pruning Shade Trees in Landscapes: A Plan for Training Shade Trees
by: Edward F. Gilman
Published: (2007-03-01)
by: Edward F. Gilman
Published: (2007-03-01)
Gainesville's Urban Forest Structure and Composition
by: Francisco Escobedo, et al.
Published: (2009-04-01)
by: Francisco Escobedo, et al.
Published: (2009-04-01)
Florida's Environment - Southeast Region
by: Martin B. Main, et al.
Published: (2007-10-01)
by: Martin B. Main, et al.
Published: (2007-10-01)
El Mango en Florida
by: Jonathan H. Crane, et al.
Published: (2006-03-01)
by: Jonathan H. Crane, et al.
Published: (2006-03-01)
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
by: Hans-Georg Rammensee, et al.
Published: (2020-05-01)
by: Hans-Georg Rammensee, et al.
Published: (2020-05-01)
Improving CD3 bispecific antibody therapy in solid tumors using combination strategies
by: Katy Lloyd, et al.
Published: (2025-02-01)
by: Katy Lloyd, et al.
Published: (2025-02-01)
A roadmap to implementing outpatient administration of bispecific antibodies in multiple myeloma
by: Alfred L. Garfall, et al.
Published: (2025-07-01)
by: Alfred L. Garfall, et al.
Published: (2025-07-01)
Elucidating heavy/light chain pairing preferences to facilitate the assembly of bispecific IgG in single cells
by: Kamal Kishore Joshi, et al.
Published: (2019-10-01)
by: Kamal Kishore Joshi, et al.
Published: (2019-10-01)
Rapid Generation of Murine Bispecific Antibodies Using FAST-Ig<sup>TM</sup> for Preclinical Screening of HER2/CD3 T-Cell Engagers
by: Hikaru Koga, et al.
Published: (2024-01-01)
by: Hikaru Koga, et al.
Published: (2024-01-01)
Bispecific Antibodies: A Smart Arsenal for Cancer Immunotherapies
by: Gihoon You, et al.
Published: (2021-07-01)
by: Gihoon You, et al.
Published: (2021-07-01)
The Role of Bispecific Antibodies in Non-Hodgkin’s Lymphoma: From Structure to Prospective Clinical Use
by: Rita Tavarozzi, et al.
Published: (2022-02-01)
by: Rita Tavarozzi, et al.
Published: (2022-02-01)
Headlines for Health! Sherlock "Radon" Holmes
by: Joy C. Jordan, et al.
Published: (2007-08-01)
by: Joy C. Jordan, et al.
Published: (2007-08-01)
A novel bispecific antibody targeting CD3 and prolactin receptor (PRLR) against PRLR-expression breast cancer
by: Yuexian Zhou, et al.
Published: (2020-05-01)
by: Yuexian Zhou, et al.
Published: (2020-05-01)
A Novel Anti-B7-H3 × Anti-CD3 Bispecific Antibody with Potent Antitumor Activity
by: Yan Feng, et al.
Published: (2022-01-01)
by: Yan Feng, et al.
Published: (2022-01-01)
Pureed Foods: Texture Testing with the Slump Test
by: Wendy J. Dahl
Published: (2016-02-01)
by: Wendy J. Dahl
Published: (2016-02-01)
Similar Items
-
Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)
by: Susanne Jung, et al.
Published: (2024-02-01) -
T cell-engaging CD276xCD3 bispecific antibody for treatment of endometrial cancer
by: S. M. Greiner, et al.
Published: (2025-07-01) -
Fc-optimized CD276 antibody enhances NK cell activation against non-small cell lung cancer
by: Sylwia A. Stefańczyk, et al.
Published: (2025-07-01) -
B7-H3-targeting Fc-optimized antibody for induction of NK cell reactivity against sarcoma
by: Ilona Hagelstein, et al.
Published: (2022-10-01) -
B7-H3: a consistent marker in metastatic colorectal cancer with potential for targeted treatment
by: Julia M. Ott, et al.
Published: (2025-08-01)
